Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
3. : I recettori adrenergici / Mario Giannella, Wilma Quaglia
| 3. : I recettori adrenergici / Mario Giannella, Wilma Quaglia |
| Autore | GIANNELLA, Mario |
| Pubbl/distr/stampa | Bologna : CLUEB, stampa 1998 |
| Descrizione fisica | XII, 158 p. ; 24 cm |
| Disciplina | 615.78 |
| Altri autori (Persone) | QUAGLIA, Wilma |
| Collana | Manuali & antologie |
| Soggetto topico | Recettori adrenergici - Chimica farmaceutica |
| ISBN | 88-491-1137-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ita |
| Record Nr. | UNISA-990000786120203316 |
GIANNELLA, Mario
|
||
| Bologna : CLUEB, stampa 1998 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Alcohol, drugs, genes and clinical laboratory : an overview for healthcare and safety professionals / / Amitava Dasgupta, McGovern Medical School, The University of Texas, Health Science Center at Houston, Houston, TX, USA
| Alcohol, drugs, genes and clinical laboratory : an overview for healthcare and safety professionals / / Amitava Dasgupta, McGovern Medical School, The University of Texas, Health Science Center at Houston, Houston, TX, USA |
| Autore | DasGupta A (Amitava) |
| Pubbl/distr/stampa | London : , : Academic Press, , [2017] |
| Descrizione fisica | 1 online resource (x, 226 pages) : illustrations |
| Disciplina | 615.78 |
| Collana | Gale eBooks |
| Soggetto topico |
Substance abuse - Genetic aspects
Alcoholism Alcoholism - Genetic aspects Drinking of alcoholic beverages Drug abuse Drug abuse - Genetic aspects Drug testing |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Alcohol a double-edged sword -- 2. Drugs of abuse -- 3. Designer drugs including bath salts and spices -- 4. Combined alcohol and drug abuse -- 5. Link between environmental factors, personality factors, and addiction -- 6. Genetic polymorphisms of alcohol metabolizing enzymes associated with protection from or increased risk of alcohol abuse -- 7. Pharmacogenomics of abused drugs -- 8. Association between polymorphisms in genes encoding various receptors, transporters, and enzymes and alcohol/drug addiction -- 9. Methods of alcohol measurement -- 10. Laboratory methods for measuring drugs of abuse in urine -- 11. Analysis of drug abuse in serum, hair, oral fluid, sweat and meconium. |
| Record Nr. | UNINA-9910583459003321 |
|
DasGupta A (Amitava)
|
||
| London : , : Academic Press, , [2017] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antidepressants : From Biogenic Amines to New Mechanisms of Action / / edited by Matthew Macaluso, Sheldon H. Preskorn
| Antidepressants : From Biogenic Amines to New Mechanisms of Action / / edited by Matthew Macaluso, Sheldon H. Preskorn |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (xii, 442 pages) : illustrations (some color), charts |
| Disciplina |
615
615.78 |
| Collana | Handbook of Experimental Pharmacology |
| Soggetto topico |
Pharmacology
Psychiatry Neurosciences Neuroscience |
| ISBN |
9783030109493
3030109496 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1: Overview and General Principles -- 1. Impact, Diagnosis, Phenomenology, and Biology -- Part 2: The Past – from antiquity to 1970 including TCAs and MAOIs -- 2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? -- Part 3: The Present- 1970 to 2016 -- 3. Clinical Implications of the STAR*D Trial -- 4. Pharmacogenomics and Biomarkers of Depression -- 5. Therapeutic Drug Monitoring of Antidepressants -- 6. Selective Serotonin Reuptake Inhibitors -- 7. Serotonin and Norepinephrine Reuptake Inhibitors -- 8. Neurostimulation Therapies -- 9. Current Role of Herbal and Natural Preparations -- Part 4: The future -- 10. Role of Inflammation in Depression and Treatment Implications -- 11. NMDA Antagonists for Treatment-Resistant Depression -- 12. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- 13. Other Antidepressants -- Part 5: Use of Antidepressants in Special Populations -- 14. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders -- 15. Treatment of Depression in Women -- 16. Management of Late-Life Depression -- 17. The Use of Antidepressants in Bipolar Depression. |
| Record Nr. | UNINA-9910337937903321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antidepressants : perspectives, medical uses and health implications / / Sharon Jenkins, editor
| Antidepressants : perspectives, medical uses and health implications / / Sharon Jenkins, editor |
| Pubbl/distr/stampa | New York : , : Nova Biomedical, , 2017 |
| Descrizione fisica | 1 online resource (171 pages) : illustrations |
| Disciplina | 615.78 |
| Collana | Pharmacology - Research, Safety Testing and Regulation |
| Soggetto topico |
Antidepressants
Depression, Mental |
| ISBN | 1-5361-0398-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910155225203321 |
| New York : , : Nova Biomedical, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The art and science of psychopharmacology : essential tools for treating anxiety, depression, bipolar disorder and psychosis / / Susan Marie
| The art and science of psychopharmacology : essential tools for treating anxiety, depression, bipolar disorder and psychosis / / Susan Marie |
| Autore | Marie Susan |
| Pubbl/distr/stampa | Eau Claire, Wisconsin : , : PESI Publishing & Media, , [2020] |
| Descrizione fisica | 1 online resource (158 pages) |
| Disciplina | 615.78 |
| Soggetto topico | Psychopharmacology |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-68373-317-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910479855803321 |
|
Marie Susan
|
||
| Eau Claire, Wisconsin : , : PESI Publishing & Media, , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The art and science of psychopharmacology : essential tools for treating anxiety, depression, bipolar disorder and psychosis / / Susan Marie
| The art and science of psychopharmacology : essential tools for treating anxiety, depression, bipolar disorder and psychosis / / Susan Marie |
| Autore | Marie Susan |
| Pubbl/distr/stampa | Eau Claire, Wisconsin : , : PESI Publishing & Media, , [2020] |
| Descrizione fisica | 1 online resource (158 pages) |
| Disciplina | 615.78 |
| Soggetto topico | Psychopharmacology |
| ISBN | 1-68373-317-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910794103303321 |
|
Marie Susan
|
||
| Eau Claire, Wisconsin : , : PESI Publishing & Media, , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The art and science of psychopharmacology : essential tools for treating anxiety, depression, bipolar disorder and psychosis / / Susan Marie
| The art and science of psychopharmacology : essential tools for treating anxiety, depression, bipolar disorder and psychosis / / Susan Marie |
| Autore | Marie Susan |
| Pubbl/distr/stampa | Eau Claire, Wisconsin : , : PESI Publishing & Media, , [2020] |
| Descrizione fisica | 1 online resource (158 pages) |
| Disciplina | 615.78 |
| Soggetto topico | Psychopharmacology |
| ISBN | 1-68373-317-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910823106903321 |
|
Marie Susan
|
||
| Eau Claire, Wisconsin : , : PESI Publishing & Media, , [2020] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Aspects of psychopharmacology / / edited by D.J. Sanger and D.E. Blackman
| Aspects of psychopharmacology / / edited by D.J. Sanger and D.E. Blackman |
| Pubbl/distr/stampa | Abingdon, Oxon : , : Routledge, , 2017 |
| Descrizione fisica | 1 online resource (240 pages) : illustrations, graphs |
| Disciplina | 615.78 |
| Altri autori (Persone) |
Blackmanderek E
SangerD. J |
| Collana | Routledge Library Editions: Addictions |
| Soggetto topico |
Psychopharmacology
Psychotropic drugs Substance abuse |
| ISBN |
1-315-53605-6
1-315-53604-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introduction to psychopharmacology and basic neuropharmacology / A.J. Greenshaw, D.J. Sanger and D.E. Blackman -- 2. Behavioural principles in psychopharmacology / James E. Barrett -- 3. Internal stimulus effects of drugs / I.P. Stolerman -- 4. Alcohol and alcoholism / Geoff Lowe -- 5. Social aspects of illegal drug use / Raymond Cochrane -- 6. Drugs and human memory / C.M. Smith -- 7. The use of drugs in psychiatry / P.E. Harrison-Read -- 8. Contemporary psychopharmacology : a review / D.J. Sanger and D.E. Blackman. |
| Record Nr. | UNINA-9910136150103321 |
| Abingdon, Oxon : , : Routledge, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Behavioral Neurobiology of GABAB Receptor Function / / edited by Styliani Vlachou, Kevin Wickman
| Behavioral Neurobiology of GABAB Receptor Function / / edited by Styliani Vlachou, Kevin Wickman |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (331 pages) |
| Disciplina | 615.78 |
| Collana | Current Topics in Behavioral Neurosciences |
| Soggetto topico |
Pharmacology
Neurosciences Psychiatry Neuroscience |
| ISBN | 3-030-91335-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- A Brief History and the Significance of the GABAB Receptor -- 1 Introduction -- 2 GABAB Receptor Structure, Function, and Distribution -- 3 GABAB Receptor Ligands: Agonists, Antagonists, and Allosteric Modulators -- 4 GABAB Receptors as Potential Therapeutic Targets -- 4.1 Drug and Alcohol Use Disorders -- 4.2 Pain and Analgesia -- 4.3 Anxiety and Mood Disorders -- 4.4 Neurodegeneration -- 4.5 Cognitive Processes in Neurodevelopment, Health and Disease -- 4.6 Other Conditions Outside the CNS -- 5 Conclusion -- References -- Structural Basis of GABAB Receptor Regulation and Signaling -- 1 Heterodimers Are the Minimal Functional Receptor Units -- 2 Signal Transduction in the Receptor Heterodimer -- 3 Auxiliary KCTD Subunits -- 4 SD-Interacting Proteins -- 5 Effector Channels -- 6 Additional Receptor-Associated Proteins -- 7 Concluding Remarks -- References -- Mechanisms and Regulation of Neuronal GABAB Receptor-Dependent Signaling -- 1 Introduction -- 2 GABABR Structure -- 2.1 Ligand Binding -- 2.2 Coupling to G Proteins -- 2.3 Cell Surface Trafficking -- 2.4 Alternative Splicing -- 2.5 Oligomerization -- 2.6 GABABR Signalosome -- 3 GABABR-Dependent Signaling in Neurons -- 3.1 GABABR Coupling to G Proteins -- 3.2 GABABR Regulation of Effectors -- 3.2.1 GIRK Channels -- 3.2.2 Voltage-Gated Ca2+ Channels -- 3.2.3 Adenylyl Cyclase -- 4 Regulation of GABABR-Dependent Signaling in Neurons -- 4.1 Desensitization -- 4.2 Phosphorylation -- 4.2.1 CaMKII -- 4.2.2 AMPK -- 4.2.3 PKA -- 4.2.4 PKC -- 4.3 Ubiquitination -- 4.4 KCTD Proteins -- 4.5 RGS Proteins -- 4.5.1 R7 RGS/Gβ5 -- 4.5.2 R4 RGS Proteins -- 4.5.3 RGS12 -- 5 Plasticity of GABABR-Dependent Signaling -- 5.1 Phosphorylation-Dependent Plasticity -- 5.2 Plasticity of 14-3-3 Proteins -- 5.3 Plasticity of RGS Regulation -- 6 Concluding Remarks -- References.
GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators -- 1 Introduction -- 2 Brief History -- 3 Structure and Signaling -- 4 Molecular Diversity and Complexity -- 5 Agonists -- 6 Partial Agonists -- 7 Antagonists -- 8 Inverse Agonists -- 9 Allosteric Modulators -- 10 Probe Dependency -- 11 Biased Agonism/Functional Selectivity -- 12 GABAB Receptor-Targeted Pharmaceuticals -- 13 Concluding Remarks -- References -- GABAB Receptors and Drug Addiction: Psychostimulants and Other Drugs of Abuse -- 1 Introduction -- 2 GABABR Signaling in the Reward Circuit -- 2.1 The VTA Microcircuit -- 2.2 GABAergic Inputs to the VTA -- 3 Impact of Addictive Drugs on GABABR Signaling in the Reward Circuit -- 3.1 Psychostimulants -- 3.2 Nicotine -- 3.3 Opioids -- 3.4 Cannabis -- 3.5 Summary -- 4 Effects of Genetic Manipulations of GABABR on Animal Models of Drug Addiction -- 5 Effects of Pharmacological Manipulations on Animal Models of Drug Addiction: Agonists, Antagonists, and Positive Allosteric ... -- 5.1 Psychostimulants -- 5.1.1 Amphetamine and Methamphetamine -- 5.1.2 Cocaine -- 5.2 Nicotine -- 5.3 Opioids -- 5.4 Other Drugs/Reinforcers -- 5.5 Stress and Addiction -- 5.6 Summary -- 6 Clinical Studies of GABABR Modulators in Drug Addiction -- 7 Conclusions -- References -- GABAB Receptors and Alcohol Use Disorders: Preclinical Studies -- 1 GABAB Receptors and Alcohol Use Disorders: Preclinical Studies -- 2 Locomotor Activity -- 3 Place Conditioning -- 4 Alcohol Withdrawal Syndrome -- 5 Alcohol Drinking -- 5.1 Acquisition and Maintenance of Alcohol Drinking -- 5.2 Binge-Like Drinking -- 5.3 Relapse-Like Drinking -- 6 Operant Alcohol Self-Administration -- 6.1 Fixed Ratio (FR) Procedure -- 6.2 Progressive Ratio (PR) Procedure -- 6.3 Extinction and Reinstatement of Alcohol Seeking Procedures -- 6.4 Appetitive-Consummatory Procedures. 7 Discussion -- References -- GABAB Receptors and Alcohol Use Disorders: Clinical Studies -- 1 Introduction -- 2 Overview of Pharmacotherapies Modulating the GABAB Receptor -- 2.1 Baclofen -- 2.2 γ-Hydroxybutyric Acid -- 3 Treatment for Alcohol Withdrawal Syndrome -- 4 Relapse Prevention in Alcohol Use Disorders -- 4.1 Baclofen: Low-to-Moderate Doses -- 4.2 Baclofen: High-Doses -- 4.3 Specific Populations -- 4.3.1 Alcohol-Related Liver Disease -- 4.3.2 Comorbid Anxiety -- 5 Meta-Analyses Assessing Baclofen´s Efficacy -- 6 Laboratory Studies Evaluating Craving and Biobehavioural Effects of Baclofen -- 6.1 Functional Brain Activation Correlates with Baclofen -- 7 Polymorphisms Associated with Baclofen Treatment Response -- 8 Safety Concerns with Baclofen -- 9 Conclusions -- References -- GABAB Receptors and Pain -- 1 Introduction -- 1.1 Pain-Related Terminology -- 2 Expression and Function of GABAB Receptors in Nociceptive Pathways -- 2.1 GABAB Receptors in Nociceptors -- 2.1.1 GABAB Receptors in Peripheral Axon Endings of Nociceptors -- 2.1.2 GABAB Receptors in Central Axon Endings of Nociceptors -- 2.2 GABAB Receptors in Dorsal Horn Interneurons and Projection Neurons -- 2.3 GABAB Receptors in Supraspinal Areas -- 2.4 GABAB Receptors in Descending Pain Control Pathways -- 3 GABAB Receptors and Pathological Pain -- 3.1 GABAB Receptors and Inflammatory Pain -- 3.2 GABAB Receptors and Neuropathic Pain -- 4 GABAB Receptors as Target for Treating Chronic Pain -- 5 Conclusions -- References -- GABAB Receptors: Anxiety and Mood Disorders -- 1 Introduction -- 2 Role of the GABAB Receptor in the Modulation of Anxiety -- 2.1 Effects of GABAB Receptor Agonists and Positive Allosteric Modulators on Anxiety-Like Behaviour -- 2.2 Effects of GABAB Receptor Loss of Function and GABAB Receptor Antagonists on Anxiety-Like Behaviour. 3 Role of the GABAB Receptor in Depression and Antidepressant Action -- 3.1 Effects of GABAB Receptor Agonists on Depression-Like Behaviour -- 3.2 Effects of GABAB Receptor Blockade or Loss of Function on Depression-Like Behaviour -- 4 Clinical Evidence of the Role of GABAB Receptor in Mood Disorders -- 5 Conclusions and Perspectives -- References -- GABAB Receptors in Neurodegeneration -- 1 Introduction -- 2 GABAB Receptor and Its Effects -- 2.1 K+ Channels -- 2.2 Ca2+ Channels -- 2.3 Inhibition of Adenylate Cyclase -- 3 GABAA Receptors -- 4 GABAB in Neurodegenerative Diseases -- 4.1 GABAB in Alzheimer´s Disease -- 4.2 GABAB in Parkinson´s Disease -- 4.3 GABAB in Temporal Lobe Epilepsy -- 5 Conclusions -- References -- GABAB Receptors and Cognitive Processing in Health and Disease -- 1 Introduction -- 2 GABAB Receptors Mechanisms of Action -- 3 Effects of GABAB Receptors on Cognitive Processes: Learning and Memory -- 3.1 GABAB Receptors, LTP and Synaptic Plasticity -- 3.2 Active and Passive Avoidance Paradigms -- 3.3 Morris Water Maze (MWM) and Radial Arm Maze (RAM) -- 3.4 Working Memory Tasks -- 3.5 Novel-Object Recognition (NOR) and (Dis)Location (NOL) Tasks -- 3.6 Other Cognitive Tasks -- 4 GABABR Involvement in Cognitive Performance of Neurodevelopmental Conditions -- 4.1 GABABRs During Embryo-Foetal Development -- 4.2 Autism Spectrum Disorder (ASD) -- 4.3 Fragile X Syndrome (FXS) -- 4.4 Down´s Syndrome (DS) -- 5 Neurodegenerative Disorders -- 5.1 Alzheimer´s Disease (AD) -- 5.2 Epilepsy -- 5.3 Autoimmune Anti-GABAB Encephalitis and Cognitive Impairments -- 6 Conclusions -- References. |
| Record Nr. | UNINA-9910522957003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Behavioral Neuroscience of Drug Discrimination / / edited by Joseph H. Porter, Adam J. Prus
| The Behavioral Neuroscience of Drug Discrimination / / edited by Joseph H. Porter, Adam J. Prus |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (324 pages) |
| Disciplina | 615.78 |
| Collana | Current Topics in Behavioral Neurosciences |
| Soggetto topico |
Neurosciences
Psychopharmacology Behavioral sciences Behavioral Sciences |
| ISBN | 3-319-98561-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | From the Contents -- Preface -- Part 1. Overview -- Part 2. The Discriminative Stimulus Properties of Drugs -- Part 3. Approaches to Drug Discrimination. |
| Record Nr. | UNINA-9910298420403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
